Fierce Pharma

DECEMBER 15, 2023

About a year after Arcutis Biotherapeutics unveiled positive data on roflumilast foam at the European Academy of Dermatology and Venereology congress 2022, the company has clinched a second FDA OK. | About a year after Arcutis Biotherapeutics unveiled positive data on roflumilast foam at the European Academy of Dermatology and Venereology congress 2022, the company has clinched a second FDA OK.

FDA 318

FDA 318

MedCity News

DECEMBER 15, 2023

WeightWatchers’ new GLP-1 program offers daily nutritional and activity targets, recommended foods, recipes, food and activity tracking, a digital community, virtual workshops and access to coaches 24/7.

Food 131

Food Management 131

Fierce Pharma

DECEMBER 15, 2023

Since Merck secured approval for kidney cancer pill and blockbuster hopeful Welireg (belzutifan) in August of 2021, sales have grown slowly but surely. | Since Merck secured approval for kidney cancer pill and blockbuster hopeful Welireg (belzutifan) in August of 2021, sales have grown slowly but surely. With a second FDA nod for a much larger patient population, the company can anticipate a more pronounced upswing in revenue from the hypoxia-inducible factor-2 alpha (HIF-2a) inhibitor.

FDA 299

FDA Sales Patients 299

European Pharmaceutical Review

DECEMBER 15, 2023

Moderna and MSD have announced follow-up data from the Phase IIb clinical trial evaluating cancer vaccine mRNA-4157 (V940) in combination with MSD’s Keytruda in patients with resected high-risk melanoma. The randomised study, KEYNOTE-942, evaluated the treatment in patients with high-risk stage III/IV melanoma. Analysis shows that after three years, treatment with mRNA-4157 (V940) in combination with checkpoint inhibitor Keytruda reduced the risk of recurrence or death by 49 percent compared w

Patients 115

Patients Pharmaceutical 115

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

DECEMBER 15, 2023

Over the years, shareholders at the Interfaith Center on Corporate Responsibility (ICCR) have repeatedly voiced concerns on a variety of subjects to top pharma companies. | Once again, shareholders with the Interfaith Center on Corporate Responsibility are raising access concerns in proposals to several top drugmakers.

Pharma 190

Pharma 190

MedCity News

DECEMBER 15, 2023

By prioritizing patient care and adapting our business models to meet the demands of our patients, we can ensure that the telehealth industry continues to provide meaningful and lasting benefits to all those who need it.

Patients 116

Patients Retail 116

pharmaphorum

DECEMBER 15, 2023

MSD and Moderna’s individualised cancer vaccine mRNA-4157 has shown impressive efficacy in a phase 2b trial in skin cancer melanoma, leaving the partners speculating about a possible regulatory filing.

108

108

European Pharmaceutical Review

DECEMBER 15, 2023

Alkermes has agreed to sell its pharmaceutical development and manufacturing facility in Athlone, Ireland to Novo Nordisk for $92.5 million. “The acquisition of the Athlone facility represents an expansion of Novo Nordisk’s global manufacturing setup and will provide Novo Nordisk with additional development and manufacturing capacity for current and future oral products,” commented Thilde G.

Manufacturing 104

Manufacturing Engineering Pharmaceutical 104

MedCity News

DECEMBER 15, 2023

To harness the best parts of AI — and avoid its worst possible outcomes — you need an AI strategy that not only includes technical implementation tactics but also prioritizes efforts to minimize bias, address ethical considerations, and build consumer trust and confidence.

Ethics 108

Ethics 108

PharmExec

DECEMBER 15, 2023

CDC data show hospitalizations among all age groups spiked by 200% for influenza, 51% for COVID-19, and 60% for respiratory syncytial virus over the past four weeks, emphasizing the need for improved outreach efforts among at-risk populations.

98

98

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

MedCity News

DECEMBER 15, 2023

Elation Health released results of a survey it conducted to learn more about how primary care physicians feel about AI scribes. It found that they haven’t really experienced the benefits of these tools yet, but they hope AI scribes can lead to time savings, reduced cognitive burden, improved job satisfaction, better patient focus and more time for care coordination.

Physicians 104

Physicians Leads Patients Healthcare 104

PharmExec

DECEMBER 15, 2023

In clinical trials, Padcev (enfortumab vedotin-ejfv) plus Keytruda (pembrolizumab) produced a statistically significant improvement in survival compared to platinum-based chemotherapy alone in patients with locally advanced or metastatic urothelial cancer.

FDA 98

FDA Patients 98

PharmaVoice

DECEMBER 15, 2023

Markups for generics can be as high as 7,000%, the researchers said.

136

136

MedCity News

DECEMBER 15, 2023

As we advocate for healthier aging, proficiency in technology emerges as not just an optional skill, but as a fundamental pillar of holistic healthcare for older adults.

Healthcare 97

Healthcare Healthcare 97

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

PharmaTimes

DECEMBER 15, 2023

The funding builds on AstriVax’s €30m in seed funding for its vaccine platform - News - PharmaTimes

103

103

MedCity News

DECEMBER 15, 2023

This week, check out news from Alpha Sophia, Encellin, CalmWave, Essential AI, and MATTER.

Healthcare 105

Healthcare Healthcare 105

PharmaTimes

DECEMBER 15, 2023

The combined system works to detect and eliminate airborne pathogens - News - PharmaTimes

107

107

pharmaphorum

DECEMBER 15, 2023

MSD claims 2nd FDA approval for Welireg, in kidney cancer Phil.

FDA 110

FDA 110

Advertisement

PharmaTimes

DECEMBER 15, 2023

The funding builds on AstriVax’s €30m in seed funding for its vaccine platform AstriVax has announced that it has been awarded a total of €3m in funding from Flanders Innovation & Entrepreneurship (VLAIO) for its therapeutic vaccine targeting chronic hepatitis B. The new funding will bring the company closer to revolutionising therapeutic vaccine development and creating a long-lasting impact in the hepatitis B field.

Patients 72

Patients 72

pharmaphorum

DECEMBER 15, 2023

Enrolment starts in trial of AI-powered Parkinson’s therapy Phil.

92

92

PharmaTimes

DECEMBER 15, 2023

The combined system works to detect and eliminate airborne pathogens A new air-filtering system developed by the University of Glasgow and Pinpoint Medical aims to detect and eliminate airborne pathogens to combat the spread of infections in hospitals. Funded by the UK Research and Innovations’ (UKRI) Engineering and Physical Sciences Research Council (EPSRC), the platform will decontaminate the air of pathogens and measure air quality to ensure a safer and healthier environment.

Engineering 55

Engineering Medical Manufacturing Patients 55

Spotio

DECEMBER 15, 2023

The wholesale distribution industry is huge, measuring $10 trillion in the US alone. To put that number in context, the retail industry measures $5.63 trillion, the finance and insurance industry measures $4.97 trillion, and the construction industry measures 2.29 trillion. Obviously, wholesalers are a critical part of the economy, which is why there are so many businesses in this sector.

CRM 52

CRM Sales Management Prospecting 52

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

Clarify Health

DECEMBER 15, 2023

Beyond Theory: Harnessing Incentives to Drive Value-Based Care Initiatives Healthcare Unbound episode recap: On this episode of the Healthcare Unbound podcast , behavioral economics expert Dr. Zeke Emanuel discusses how to create physician incentives to control costs and improve outcomes in healthcare. Physician incentives should be real, substantial, and timely to get the desired positive response from doctors and drive value-based care payment models.

Physicians 52

Physicians Doctors Healthcare Healthcare 52

Pharmaceutical Commerce

DECEMBER 15, 2023

The FDA previously granted the application for Padcev (enfortumab vedotin-ejfv) plus Keytruda (pembrolizumab) with priority review and breakthrough designation for patients with locally advanced or metastatic urothelial cancer.

FDA 52

FDA Patients 52

PharmExec

DECEMBER 15, 2023

Erasca will initiate the pivotal SEACRAFT-2 trial in the first half of 2024 to evaluate naporafenib in combination with trametinib in adults with unresectable or metastatic melanoma with an NRAS mutation.

FDA 52

FDA 52

pharmaphorum

DECEMBER 15, 2023

As conversations surrounding Equality, Diversity, and Inclusion (EDI) in health and care research participation continue to broaden, we are also expanding our scope of involvement and inclusivity. However, achieving the ambitious goal of EDI remains a challenge. In this interactive webinar, brought to you by the National Institute for Health and Care Research (NIHR), we delve beneath the surface of EDI in research to unpick common challenges in offering equal participation opportunities in the U

52

52

Advertisement

Distribution

Pharmaceutical Commerce

DECEMBER 15, 2023

Creating a meaningful digital transformation requires pharmaceutical manufacturing companies to incorporate the right technologies, processes, and systems to reach their fullest potential.

Pharmaceutical manufacturing 52

Pharmaceutical manufacturing Pharma Manufacturing Pharmaceutical 52

Contrarian Sales Techniques

DECEMBER 15, 2023

"Passive income," "huge commissions," "lifestyle business" - these are the siren calls of countless online marketing schemes, promising riches with minimal effort. But before you dive headfirst into the latest "secret system," let's shed some light on the reality of affiliate marketing , particularly the red flags you should be wary of. The Glimmering Myth: The email you received paints a picture of affiliate marketing as a magic money machine, where commissions roll in effortlessly while you sl

Marketing 52

Marketing Sales Education 52

Pharmaceutical Commerce

DECEMBER 15, 2023

The FDA based the approval Merck’s Welireg (belzutifan) on findings from the randomized, open-label, Phase III LITESPARK-005 trial, which compared Welireg to Afinitor for the treatment of advanced RCC that has progressed after prior treatment with PD-1/L1 and VEGF-TKI therapies.

FDA 52

FDA Patients 52

PharmExec

DECEMBER 15, 2023

Adjuvant treatment with Moderna’s mRNA-4157 (V940) in combination with Merck's Keytruda lowered the risk of recurrence or death by 49% compared with Keytruda monotherapy.

52

52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales